You Tube Video Explains MRSA Threat

Posted in These Categories: Studies and Hospital Acquired Infections

Medizone International, Inc. (OTCBB/OTCQB: MZEI)
(http://medizoneint.com)

This You Tube Video explains clearly and simply how the two common conditions caused by hospital-acquired infections (HAIs) killed 48,000 people and ramped up health care costs by $8.1 billion in 2006 alone.

AsepticSure™ has the potential to become fundamental in hospital management.

The volume of the use for a commercial product like the AsepticSure™ with reliable 6 log (99.9999%) “Super Bug” kill rate on an international scale is tremendous.

Last week Medizone International noted that a typical protocol might have a hospital perform a first cleaning of 95 minutes to fully sterilize the space, which would be followed by cleanings, perhaps as infrequently as one time per week for lower risk settings, requiring only 80 minutes to complete.

The study released in February 2010 in the Archives of Internal Medicine is the largest nationally representative study to date of the toll taken by sepsis and pneumonia, two conditions often caused by deadly microbes, including the antibiotic-resistant bacteria MRSA.  This YouTube Video features the author of a recent Duke University Study which looks at the prevalence of MRSA in hosptials.

“In many cases, these conditions could have been avoided with better infection control in hospitals,” said Ramanan Laxminarayan, Ph.D., principal investigator for Extending the Cure, a project examining antibiotic resistance based at the Washington, D.C. think-tank Resources for the Future.

“Infections that are acquired during the course of a hospital stay cost the United States a staggering amount in terms of lives lost and health care costs,” he said. “Hospitals and other health care providers must act now to protect patients from this growing menace.”

Laxminarayan and his colleagues analyzed 69 million discharge records from hospitals in 40 states and identified two conditions caused by health care-associated infections: sepsis, a potentially lethal systemic response to infection and pneumonia, an infection of the lungs and respiratory tract.

The researchers looked at infections that developed after hospitalization. They zeroed in on infections that are often preventable, like a serious bloodstream infection that occurs because of a lapse in sterile technique during surgery, and discovered that the cost of such infections can be quite high: For example, people who developed sepsis after surgery stayed in the hospital 11 days longer and the infections cost an extra $33,000 to treat per person.

Even worse, the team found that nearly 20 percent of people who developed sepsis after surgery died as a result of the infection. “That’s the tragedy of such cases,” said Anup Malani, a study co-author, investigator at Extending the Cure, and professor at the University of Chicago. “In some cases, relatively healthy people check into the hospital for routine surgery. They develop sepsis because of a lapse in infection control—and they can die.”

The team also looked at pneumonia, an infection that can set in if a disease-causing microbe gets into the lungs—in some cases when a dirty ventilator tube is used. They found that people who developed pneumonia after surgery, which is also thought to be preventable, stayed in the hospital an extra 14 days. Such cases cost an extra $46,000 per person to treat. In 11 percent of the cases, the patient died as a result of the pneumonia infection.

According to the authors, HAIs frequently are caused by microbes that defy treatment with common antibiotics. “These superbugs are increasingly difficult to treat and, in some cases, trigger infections that ultimately cause the body’s organs to shut down,” said Malani.

Based on their research, study authors were able to estimate the annual number of deaths and health care costs due to sepsis and pneumonia that is actually preventable.

This study was supported by the Robert Wood Johnson Foundation’s Pioneer Portfolio, which funds innovative ideas that may lead to breakthroughs in the future of health and health care.

The sheer scope of the application of AsepticSure™ is incredibly broad.

Medizone International, Inc. is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospitals, sports training facilities, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures. Successful decontamination by AsepticSure™ to the 6 log standard or greater has been demonstrated with C.difficile, E coli, Pseudomonas aeruginous, MRSA, VRE and Bacillius subtilis.

( http://www.youtube.com/watch?v=ivz6nw2wMJk )

Medizone International, Inc.
Post Office Box 742
Stinson Beach, CA 94970
Telephone: 415-868-0300
Fax: 415-868-2344

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Tweet This Post

Tags: hospital acquired infections hospital sterilization system MRSA